Photo from wikipedia
To study visual outcome and number of annual injections in treatment‐naïve patients with neovascular age‐related macular degeneration (nAMD) before and after a change in first‐line therapy from ranibizumab to aflibercept… Click to show full abstract
To study visual outcome and number of annual injections in treatment‐naïve patients with neovascular age‐related macular degeneration (nAMD) before and after a change in first‐line therapy from ranibizumab to aflibercept in a high‐volume clinical practice.
Keywords:
outcome number;
macular degeneration;
age related;
related macular;
visual outcome;
neovascular age
Journal Title: Acta Ophthalmologica
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Ophthalmologica
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!